A 2025 meta-analysis of 16 studies involving 6,098 participants found no statistically significant difference between intramuscular, oral, and sublingual B12 supplementation routes (p=0.270)
AOD 9604 is hypothesized to potentially induce lipolysis without significant impacts on insulin and IGF-1 levels in laboratory models, potentially moderating risks associated with glucose intolerance in these experimental settings
Subsequently, for these data as well as the alpha diversity analyses, each treatment group (within each phylum or genus for the relative abundance data) was analyzed for normal distribution (ShapiroWilk test) and the data across groups were tested for homoscedasticity (BrownForsythe test)
So, how do we solve this problem
Get started with ReadyRx NAD+ Nasal Spray Realistic Expectations: What NAD+ Therapy Can and Cannot Promise Setting honest expectations is the most important section in any guide about a longevity-focused therapy, and this one is no exception